Evidence map›Paper›PMID 35663738›Full record

ArticleHeliyon2022

An aqueous extract of

Antoine Kavaye Kandeda, Stéphanie Lewale, Etienne Djeuzong, J Kouamouo, Théophile Dimo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. An Examination into the Safety and Efficacy of KhapregesicInternational journal of women's health · 2025
    Trial
  3. Potential ofIBRO neuroscience reports · 2025
    Article
  4. Article
  5. Heliyon · 2024
    Article
  6. Aqueous extract ofFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Antoine Kavaye KandedaDepartment of Animal Biology and Physiology, University of Yaoundé I, P.O. Box 812, Yaoundé, Cameroon.
Stéphanie LewaleDepartment of Pharmacy, University of Mountains, P.O. Box 208, Banganté, Cameroon.
Etienne DjeuzongDepartment of Pharmacy, University of Mountains, P.O. Box 208, Banganté, Cameroon.
J KouamouoDepartment of Pharmacy, University of Mountains, P.O. Box 208, Banganté, Cameroon.
Théophile DimoDepartment of Animal Biology and Physiology, University of Yaoundé I, P.O. Box 812, Yaoundé, Cameroon.
Université des Montagnes · CMUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethnopharmacological relevance: Temporal lobe epilepsy is the most common form of drug-resistant epilepsy. Therefore, medicinal plants provide an alternative source for the discovery of new antiepileptic drugs. Aim of the study: This study was aimed at investigating the antiepileptic- and anxiolytic-like effects of an aqueous extract of Methods: Seventy-two rats received a single dose of kainate (12 mg/kg) intraperitoneally. Those that exhibited two hours of Results: The aqueous extract of Conclusion: These findings suggest that the aqueous extract of

Indexed as

AnxietyGABAKhaya senegalensisOxidative stressTemporal lobe epilepsy

Identifiers

PMID35663738
PMCPMC9160348
OpenAlexW4281967963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.